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Echocardiography has visualized proximal segments of cor-
onary arteries almost since the advent of the technique (1,2) .
Transesophageal echocardiography with its higher fre-
quency transducers and proximal acoustic window has rea-
wakened interest in echocardiographic coronary imaging . A
high success rate of >90% in the left coronary system and
--50% in the right coronary artery has been consistently
achieved by transesophageal echocardiography in imaging
coronary arteries (3®5). More recently, transesophageal
Doppler echocardiography has been used to generate a
time-velocity image to measure coronary blood flow velocity
and pharmacologically induced coronary flow reserve . Cor-
onary flow reserve has been commanding increasing atten-
tion of late as a marker of clinical and pathophysiologic
importance of coronary stenosis (6) because visual inspec-
tion by angiot;raphy of the anatomic severity of a coronary
stenosis does not consistently reflect its physiologic impor-
tance (7) .
Present study . In this issue of th Journal, Iliceto et al . (8)
describe the use of a new transpulmonary galactose-based
contrast agent, SHU-508A (Schering AG, erlin) to improve
the Doppler flow signal obtained from the left coronary
artery during transesophageal echocardiography . In 35 pa-
tients undergoing transesophageal echocardiography for
clinical indications, they performed four peripheral contrast
injections of varying doses of SHU-508A and qualitatively
graded pulsed and color Doppler flow imaging in the left
coronary artery . They showed a significant improvement in
yield and quality of Doppler signals after use of the contrast
agent. The percent of "optimal" color Doppler
signals
improved from 20%, 11% and 3i% to 74%, 74% and 51% for
the left main, left anterior descending and left circumflex
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arteries, respectively, after injection of 10 ml of 300 mg/ml of
contrast medium . Similarly, the percent of optimal pulsed
Doppler signals for the left anterior descending artery im-
proved from '23%c to 66Th after injection of 10 ml of 300 mg/ml
of 51-11;'-508A . Contrast injection also increased the length
acid width of color flow Doppler signals from 5 .75 and
1 .51 mm to 17.04 and 4 .21 mm, respectively .
Contrast enha cement . The principle of contrast en-
hancement for Doppler echocardiography is that an increase
in the reflectivity of blood obtained by using gaseous mi-
crobubbles augments the display of low intensity Doppler
signals, improving the signal to noise ratio . This amplifica-
tion allows recognition of border areas of the signal that
would have been interpreted as noise and not displayed
before contrast enhancement . Microbubbles within blood or
a fluid analog scatter and reflect ultrasound waves more than
do red blood cells .
Gramiak and Shah (9) first described this phenomenon of
contrast enhancement in 1968, using indocyanine green .
`)'lieu- technique has been widely replaced by the use of
simple agitated saline solution which, although very useful
for detection of intracardiac shunts and enhancing right-
sided signals, is limited to right heart applications . Most
older contrast agents, such as saline solution, are not capa-
ble of transpulmonary passage because they lack intravas-
cular stability and they produce bubbles that are larger than
capillaries and are therefore completely filtered . However,
in the last decade, newer agents with improved intensity,
stability and reproducibility have been developed for use in
contrast echocardiography . The use of a mechanical sonica-
tor, instead of hand agitation, has allowed production of
more stable bubbles that are smaller and uniform in size (10) .
Two new commercial agents, Albunex (Molecular Biosys-
terns) and SHIP-508A, as well as sonicated albumin mi-
crobubbles, seem to have the right characteristics to allow
passage through the pulmonary circulation .
The ability to undergo transpulmonary passage allows
new applications for contrast echocardiography . In re-
ports in the last few months, sonicated albumin (11) and
saccharide-based agents (12) have been shown to enhance
left-sided pulsed and color flow Doppler signals, in condi-
tions such as mitral regurgitation, after peripheral venous
injections. Sonicated albumin has also been shown to im-
prove Doppler signal quality in patients with aortic stenosis
(13). Left-sided contrast is also potentially useful for improv-
ing automatic edge detection and allowing more accurate
quantification of ventricular volumes and ejection fraction,
as well as of shunt and regurgitant lesions .
An exciting application for left ventricular contrast is
myocardial contrast enhancement . Currently, this has been
achieved only by aortic root and intracoronary injection .
However, several newer agents being developed may allow
a high enough concentration of microbubbles to survive
transpulmonary passage by peripheral injection and enter
the coronary circulation, DeMaria et al . (14) recently re-
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ported achieving dense myocardial opacification in an animal
model using a contrast agent that is a liquid emulsion in vivo
and forms echogenic dodecafluoropentane
gaseous n
scrobubbles in vitro (14) . At least three other agents being
developed commercially also show great promise in allowing
myocardial contrast enhancement by peripheral injection
.
This property would open the way for use of echocardiog-
raphy to assess myocardial viability in settings such as the
emergency room, the coronary care unit and the cardiac
catheterization laboratory . The safety of these new agents in
humans remains to be demonstrated . Currently, only Al-
bunex has been tested in multicenter trials and found to be
safe (15).
Strength and weaknesses. iliceto et at. (8) have demon-
strated that SHU 508a is useful for improving the signal
quality of Doppler imaging from the left coronary artery .
This easily prepared agent, which can be administered by
peripheral venous injection, has great potential for permit-
ting reliable semi-invasive measurement of coronary flow
reserve. Interobserver and intraob , .erver variability are low
with this technique . Nevertheless, several questions remain
.
The optimal dose of contrast medium has yet to be estab-
lished . In this study, the 300-mg/ml concentration achieved
the highest percent of optimal color Doppler signals ; how-
ever, in 11% of injections, 10 ml of this concentration caused
shadowing artifact to obscure the artery . Other studies have
used between 4 and 16 ml of a 300- to 400-mg/ml concentra-
tion. The effect of preexisting pulmonary disease on the
passage of this agent also needs to be established . The
present study used monoplane imaging and does not com-
ment on how Doppler yield may change with use of currently
available biplane and multiplane transducers . It provides no
hemodynamic and physiologic data on the potential adverse
effect of this agent in humans, and no large-scale studies
addressing this question have been reported. Other studies
using SHU-508A in a total of 38 volunteers (12,16) reported
no clinically relevant changes in heart rate, blood pressure,
electrocardiographic, blood chemistry or hematologic find-
ings. Finally, it is also important to know whether the
sugar-based agent itself produces coronary vasodilation or
changes in coronary flow velocity .
Coronary flow reserve by transesophageal Doppler echo-
cardiography . iliceto et al. (17) also were first to report (in
1991) the use of transesophageal Doppler echocardiography
to evaluate coronary flow reserve . There was a 69% (27 of
39) success rate in obtaining Doppler flow signals in the
proximal left anterior descending coronary artery . They
showed a significant difference in coronary flow reserve
between patients with coronary artery disease and normal
subjects, with minimal short-term interobserver and intraob-
server variability in blood flow measurements. Since that
report, there have been nine additional reports (all abstracts)
of the use of transesophageal Doppler echocardiography to
measure coronary flow reserve in 189 additional patients
with an implied 99% success rate (18-26) . These studies
have used transesophageal Doppler echocardiography to
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evaluate patients with aortic stenosis and regurgitation,
dilated cardiomyopathy, syndrome X, hypertrophic obstruc-
tive cardiomyopathy, as well as coronary artery disease . Our
own experience shows an 85% success rate in obtaining
optimal Doppler imaging, with a significant learning curve
that continues for nearly I year (26) .
One recent abstract (27) also described the use of
saccharide-based contrast in 10 patients, with similar results
to the current findings . Certainly, the data of iliceto et al . (8)
show a promising future for improvement of coronary Dopp-
ler flow signals by this new left-sided contrast agent .
Contrast-enhanced transesophageal Doppler echocardiogra-
phy appears to be an exciting new method allowing semi-
invasive assessment of coronary flow reserve . Further stud-
ies in more patients are needed to determine whether
saccharide-based contrast agents are a safe bet to sweeten
the coronary flow reserve pot .
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